Literature DB >> 6892650

Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.

C M Feek, J S Sawers, W J Irvine, G J Beckett, W A Ratcliffe, A D Toft.   

Abstract

We assessed the efficacy of the combination of propranolol and potassium iodide in the preparation of patients with Graves' disease for thyroid surgery. Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol. In contrast to previous experience with either drug used singly, the combined regimen caused a significant fall in mean serum total thyroxine and triiodothyronine to levels in the euthyroid range before operation (P less than 0.001). There was also a significant fall (P less than 0.05) before operation and transient rise after operation in serum reverse triiodothyronine. These preliminary results suggest that the combination of potassium iodide and propranolol may prove to be the optimum preoperative preparation for patients with Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892650     DOI: 10.1056/NEJM198004173021602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

1.  Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide.

Authors:  Anthony J Fischer; Nicholas J Lennemann; Sateesh Krishnamurthy; Péter Pócza; Lakshmi Durairaj; Janice L Launspach; Bethany A Rhein; Christine Wohlford-Lenane; Daniel Lorentzen; Botond Bánfi; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-25       Impact factor: 6.914

2.  Thyroid surgery for Graves' disease.

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

3.  Failure to reach euthyroidism with potassium iodide and propranolol in preparation of patient with Graves' disease for surgery.

Authors:  J Unger; E Couturier; M Durez; P Dor
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

4.  Effects of short-term potassium iodide treatment for thyrotoxicosis due to Graves disease in children and adolescents.

Authors:  Kyung Uk Jeong; Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-12-31

Review 5.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

6.  Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.

Authors:  Toyoyoshi Uchida; Hiromasa Goto; Takatoshi Kasai; Koji Komiya; Kageumi Takeno; Hiroko Abe; Nayumi Shigihara; Junko Sato; Akira Honda; Tomoya Mita; Akio Kanazawa; Yoshio Fujitani; Hirotaka Watada
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

7.  Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.

Authors:  Reese W Randle; Maria F Bates; Kristin L Long; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Surgery       Date:  2017-11-03       Impact factor: 3.982

Review 8.  Hyperthyroidism. Current drug therapy.

Authors:  J R Stockigt; D J Topliss
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

9.  Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocr Connect       Date:  2017-03-21       Impact factor: 3.335

Review 10.  Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocrine       Date:  2017-10-26       Impact factor: 3.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.